Combination of intravenous immunoglobulins and lenalidomide in the treatment of scleromyxedema

Journal of the American Academy of Dermatology

Volumn 69, Issue 2, 2013, Pages 319-320

  Brunet Possenti, Florence ^a   Hermine, Olivier ^b   Marinho, Eduardo ^a   Crickx, Béatrice ^a   Descamps, Vincent ^a  

^a BICHAT HOSPITAL   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; LENALIDOMIDE;

ADULT; CASE REPORT; CONSTIPATION; CYTOPENIA; HISTOPATHOLOGY; HUMAN; INFECTION RISK; LETTER; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; NEUROPATHY; PAPULE; PLASMA CELL DYSCRASIA; PRIORITY JOURNAL; SCLEROMYXEDEMA; SIDE EFFECT; SKIN NODULE; SOMNOLENCE; THROMBOEMBOLISM;

EID: 84880348952     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.01.028     Document Type: Article

References (5)

1. F. Rongioletti, and A. Rebora Updated classification of papular mucinosis, lichen myxoedematous, and scleromyxedema J Am Acad Dermatol 44 2001 273 281
2. S. Caradonna, and H. Jacobe Thalidomide as a potential treatment for scleromyxedema Arch Dermatol 140 2004 277 280
3. S.V. Rajkumar Multiple myeloma: 2011 update on diagnosis, risk-stratification, and management Am J Hematol 86 2011 57 65
4. F. Davies, and R. Baz Lenalidomide mode of action: linking bench and clinical findings Blood Rev 24 Suppl 1 2010 S13 S19
5. M. Blank, Y. Levy, H. Amital, Y. Shoenfeld, M. Pines, and O. Genina The role of intravenous immunoglobulin therapy in mediating skin fibrosis in tight skin mice Arthritis Rheum 46 2002 1689 1690